You are on page 1of 1

Indian Pharmacopoeia Commission organizes CME on Pharmacovigilance in technical collaboration with IMA TNSB

Dear Friends, We are glad to share with all of you and invite you to be part of yet another novel initiative of IMA TNSB, namely organizing a CME on Pharmacovigilance and the role of practising doctors in it, in association with the Indian Pharmacopoeia Commission, which is the National Coordination Centre for the Pharmacovigilance Programme of India under the aegis of the Ministry of Health and Family Welfare, Government of India, at Chennai on Saturday 22-Feb-2014 between 1 PM and 6 PM. The World Health Organization defines Pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem (pertaining to the usage of medications and/or medical devices during clinical trials as well as after the drug or device has been approved for marketing). The aims of pharmacovigilance are to enhance patient care and patient safety in relation to the use of medicines throughout the world; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines. The primary objective of pharmacovigilance is to ensure that any therapy renders more benefit than risk to the consumer. The Indian Pharmacopoeia Commission has been organizing nationwide CMEs to create awareness about the Pharmacovigilance Programme of India (PvPI) as well as the roles and responsibilities of medical practitioners in reporting suspected adverse drug reactions to PvPI. With the IMA Headquarters already recognizing the importance of pharmacovigilance and having established the IMA Pharmacovigilance Education Cell almost a decade ago, it is evident that achieving excellence in Pharmacovigilance in India is a shared goal for PvPI and IMA. At a time when pharmacovigilance becomes more and more significant with the sudden withdrawal of high-profile drugs from the market and their subsequent conditional re-introduction, IMA TNSB is proud to collaborate with the Indian Pharmacopoeia Commission. We look forward to meeting a good number of our members at this CME. Dr. M. Balasubramanian President, IMA TNSB Dr. C. N. Raja Hon. Secretary, IMA TNSB

Date: Saturday, 22-Feb-2014 Lunch: 1 to 1:30 PM

VENUE Sri Krishna Gana Sabha, 20, Maharajapuram Santhanam Road, T. Nagar, Chennai - 600017

Time: 1 PM to 6 PM Tea: 5:30 to 6 PM

For free registration, please contact: Dr J Vijay Venkatraman Hon. Secretary Elect (2015), IMA Coimbatore Branch Phone: 82207-63222, 94421-55511 E-mail: info@oviyamedsafe.com

You might also like